SCHEMBL17295476

SCHEMBL17295476

CC(C)CN1C(=O)C(=Cc2ccc3[nH]cnc3c2)SC1=Nc1ccc(F)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CA9 Q16790 3/20 0.48
▸ MGAM O43451 2/20 0.48
▸ CA12 O43570 2/20 0.48
▸ CA1 P00915 2/20 0.48
▸ CA2 P00918 2/20 0.48
▸ ALDH1A1 P00352 6/20 0.45
▸ CYP3A4 P08684 1/20 0.45
▸ CYP2C9 P11712 1/20 0.45
▸ MEN1 O00255 4/20 0.45
▸ KMT2A Q03164 4/20 0.45
▸ MAPT P10636 4/20 0.45
▸ NPSR1 Q6W5P4 4/20 0.45
▸ FAAH O00519 1/20 0.44
▸ POLB P06746 1/20 0.44
▸ PTPN1 P18031 6/20 0.43
▸ SMN1; SMN2 Q16637 2/20 0.42
▸ BLM P54132 1/20 0.41
▸ AURKA O14965 1/20 0.40
▸ ITGB3 P05106 1/20 0.40
▸ ITGAV P06756 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17295473 1.00 CA9 (0.48) CA9MGAMCA12CA1CA2
SCHEMBL19096572 0.92 ALDH1A1 (0.48) CA9MGAMCA12CA1CA2
SCHEMBL17295453 0.84 MGAM (0.49) CA9MGAMCA12CA1CA2
SCHEMBL17295450 0.84 MGAM (0.49) CA9MGAMCA12CA1CA2
SCHEMBL17295307 0.81 MGAM (0.49) CA9MGAMCA12CA1CA2
SCHEMBL17295305 0.81 MGAM (0.49) CA9MGAMCA12CA1CA2
SCHEMBL17295413 0.81 FAAH (0.56) CA9MGAMCA12CA1CA2
SCHEMBL17295411 0.81 FAAH (0.56) CA9MGAMCA12CA1CA2
SCHEMBL19096508 0.80 FAAH (0.51) CA9MGAMCA12CA1CA2
SCHEMBL19096516 0.79 CA9 (0.58) CA9MGAMCA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3148990-A1 THIAZOLIDINONE COMPOUNDS AND THEIR USE IN THE TREATMENT OF PSYCHIATRIC OR NEUROLOGICAL DISORDERS AND INFLAMMATION, IN PARTICULAR NEUROINFLAMMATION Universität Bern (CH) 2017-04-05 — — EP disclosed
WO-2015181337-A1 THIAZOLIDINONE COMPOUNDS AND THEIR USE IN THE TREATMENT OF PSYCHIATRIC OR NEUROLOGICAL DISORDERS AND INFLAMMATION, IN PARTICULAR NEUROINFLAMMATION Universität Bern (CH) 2015-12-03 — — WO disclosed
Send feedback